Back to Walleye Capital LLC Walleye Capital LLC

RLMDRLMD
8 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in RELMADA THERAPEUTICS INC

Walleye Capital LLC holds 616,238 shares of RLMD (RELMADA THERAPEUTICS INC), worth $4.3M as of 2026-Q2. This is a new position. RLMD represents 0.0% of Walleye Capital LLC's portfolio.

Current Value

$4.3M

Current Shares

616,238

Total Value Change

+$3.8M

Total Shares Change

+595,419

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
616,238
-
$4.3M0.0%$6.92
37
2023-Q2
Exited
0
-100.0%
$00.0%$2.49
0
2023-Q1
Decreased
262,481
-44.6%
$593,2070.0%$2.24
0
2022-Q4
New
473,683
-
$1.7M0.0%$3.49
36
2022-Q3
Exited
0
-100.0%
$00.0%$36.19
0
2022-Q2
Decreased
106,420
-13.6%
$2M0.1%$19.34
0
2022-Q1
Increased
123,229
+491.9%
$3.3M0.1%$26.07
43
2021-Q4
New
20,819
-
$469,0000.0%$21.71
33

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used